Read More 2 minute read Analyst Ratings Analyst Expectations for Accolade’s Future By Benzinga Insights March 23, 3:00 PM Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish… ACCD
Read More 7 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For March 23, 2023 By Benzinga Insights March 23, 11:00 AM Upgrades For PulteGroup Inc (NYSE:PHM), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the… ACCD
Read More 7 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For March 23, 2023 By Benzinga Insights March 23, 11:00 AM Upgrades For PulteGroup Inc (NYSE:PHM), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the… ACCD
Read More 2 minute read Intraday Update Markets Movers News Penny Stocks Small Cap Trading Ideas KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday By Lisa Levin March 23, 10:39 AM U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session. ACCD
Read More 1 minute read Analyst Ratings Downgrades News Price Target Jefferies Downgrades Accolade to Hold, Announces $14 Price Target By Benzinga Newsdesk February 9, 6:37 AM Jefferies analyst Glen Santangelo downgrades Accolade (NASDAQ:ACCD) from Buy to Hold and announces $14 price target. ACCD
Read More 1 minute read Analyst Color Analyst Ratings General Health Care Initiation Movers News Price Target Small Cap Trading Ideas Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’ By Vandana Singh February 2, 1:51 PM Raymond James initiated coverage on Accolade Inc (NASDAQ:ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected… ACCD
Read More 1 minute read Analyst Ratings Initiation News Price Target Raymond James Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $15 By Benzinga Newsdesk February 2, 6:00 AM Raymond James analyst John Ransom initiates coverage on Accolade (NASDAQ:ACCD) with a Outperform rating and announces Price Target of $15. ACCD
Read More 1 minute read Analyst Color Analyst Ratings Earnings General Guidance Health Care Movers News Small Cap Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop By Vandana Singh January 10, 4:17 PM Accolade Inc (NASDAQ:ACCD) posted Q3 FY23 sales of $90.95 million, beating the consensus of $87.53 million. The company posted an… ACCD
Read More 1 minute read Analyst Color Analyst Ratings News Price Target Reiteration Small Cap Tech Accolade Analyst Finds Stock Attractively Valued Post Q3 Beat, T-5 Contract Win By Anusuya Lahiri January 10, 3:18 PM Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) and set a price target of $15.00. The re-rating reflected… ACCD
Read More 4 minute read Intraday Update Markets Movers News Penny Stocks Short Sellers Small Cap Trading Ideas Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session By Lisa Levin January 10, 3:11 PM Gainers ACCD